Related Experiment Video
Updated: Aug 23, 2026

Production and Use of Customizable Agarose Molds for Scaffold-Free Mouse Ovarian Follicle Culture
Published on: October 24, 2025
[Activation in the metaloproteinases complex in the follicle-embryonic generative capability]
Gerardo Barroso1, Clara Corona de Lau, Julio González
1Unidad de Reproducción Asistida, Departamento de Ginecología y Obstetricia, Clínica Lomas Altas, México, DF.
Objective:
To evaluate the impact of the enzymatic inhibition complex of metaloproteinases [TIMP(MMP-3 stromelisine-1)] in follicle/genesis processes and their ovule/embryonic subsequent development in stimulated cycles.
Type Of Study:
Prospective longitudinal in research center.
Materials And Methods:
A total of 20 patients were evaluated in vitro fertilization cycles measuring matrix metaloproteinases concentrations in days 3 and 12 of ovarian stimulation, as well as in the follicular liquid at the moment of ovarian retrieval. The determination of [TIMP/(MMP-3 stromelisine-1)] was done by ELISA and monoclonal antibodies type of immunoassay methods. For its statistical evaluation were applied linear regression models ( r/r2 ) and Kolmogorov-Smirov test comparing the two groups where values were expressed in agreement at its mean, standard deviation and a significance of p < 0.05.
Results:
For regression models was found a positive correlation between basal FSH and the age of patients [(r2 = 0.26)(p = 0.003)], dividing groups in older and younger patients than 35 years; it was observed significant difference in metaloproteinases concentration as in serum concentration (days 3 and 12 of stimulation) as in the follicular liquid. A decrease in the 14% [(TIMP/(MMP-3/stromelisine-1)] complex concentration was increasing in accordance at the female patients age.
Conclusions:
The matrix metaloproteinases complex study has allowed observing a status not only in the ovular quality but in the embryonic development and fertilization processes too.
Insights
The study found that the tissue inhibitor of metalloproteinase (TIMP) to matrix metalloproteinase-3 (MMP-3) complex concentration decreases with age, impacting ovular quality and embryonic development in women undergoing in vitro fertilization.
Area of Science:
- Reproductive Endocrinology
- Biochemistry
- Infertility Research
Context:
- In vitro fertilization (IVF) cycles are crucial for assisted reproduction.
- Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play roles in tissue remodeling, including ovarian function.
- Understanding the TIMP/MMP complex in stimulated cycles is vital for improving IVF outcomes.
Purpose:
- To investigate the impact of the tissue inhibitor of metalloproteinase (TIMP) to matrix metalloproteinase-3 (MMP-3) complex on follicle development and subsequent ovule and embryonic development during stimulated IVF cycles.
- To correlate TIMP/MMP-3 concentrations with patient age and ovarian stimulation parameters.
Summary:
- This prospective longitudinal study evaluated 20 patients undergoing IVF.
- Matrix metalloproteinase concentrations in serum and follicular fluid were measured during stimulation and retrieval.
- A positive correlation was observed between basal FSH and patient age (r2 = 0.26, p = 0.003).
- Significant differences in MMP concentrations were found between age groups (<35 vs. >35 years).
- The TIMP/MMP-3 complex concentration decreased by 14% with increasing female patient age.
Impact:
- The study highlights the role of the TIMP/MMP-3 complex in assessing ovular quality and embryonic development.
- Findings suggest that age-related changes in MMP complex influence IVF success.
- This research provides insights into biomarkers for predicting reproductive outcomes in assisted reproduction technologies.
Related Concept Videos
Folliculogenesis
Fertilization
Oogenesis
Spermatogenesis
Cleavage and Blastulation
Ovarian Cycle

